Hubungan antara nilai ankle brachial index (ABI) dengan kolesterol total pada anak penderita sindrom nefrotik
DAFTAR PUSTAKA
1. Park
SJ, Shin JI. Complications
of nephrotic syndrome.
Korean J Pediatr.
2011;54(8):322-8.
2. Davin JC, Rutjes NW. Nephrotic syndrome: from bench to treatment. Int J Nephrol.
2011;1-6.
3. Noer MS. Sindrom nefrotik idiopatik. Dalam: Noer MS, Soemyarso NA, Subandiyah
K, Prasetyo RV, Alatas H, dkk, penyunting. Kompendium nefrologi anak. Jakarta:
UKK nefrologi IDAI; 2011.h.72-87.
4. Pais P, Avner ED. Nephrotic syndrome. Dalam: Kliegman RM, Stanton BF, St.Geme
JW, Schor NF, Behrman RE, penyunting. Nelson texbook of pediatrics. Edisi ke-19.
USA: Elsevier saunders; 2011.h.1801-7.
5. Valentini RP, Smoyer WE. Nephrotic syndrome. Dalam: Kher KK, Schnaper HW,
Makker SP, penyunting. Clinical pediatric nephrology. Edisi ke-2. USA: Informa
healthcare; 2007.h.155-94.
6. Mohammed SM, Elmazary A, Taha HT. Ankle brachial index in children with steroidresistant nephrotic syndrome. Sultan Qaboos University Med J. 2013;13(1):88-92.
7. Willenberg T, Diehm N, Zwahlen M, Kalka D, Do DD, dkk. Impact of Long-term
corticosteroid therapy on the distribution pattern of lower limb atherosclerosis. Eur J
Vasc Endovasc Surg. 2010;39:441-6.
8. Shammas NW. Epidemiology, classification, and modifiable risk factors of peripheral
arterial disease. Vascular health and risk management. 2007;3(2):229-34.
9. Ramalhao C, Alves A, Pereira A. Arterial peripheral disease-assessment by ankle
brachial index. J Cardiol curr Res. 2014;1(4):1-6.
Universitas Sumatera Utara
10. Papa EDE, Helber I, Ehrlichmann MR, Alves CMR, Makdisse M, Matos LN, dkk.
Ankle-brachial index as a predictor of coronary disease events in elderly patients
submitted to coronary angiography. Clinics. 2013;68(12):1481-7.
11. Eddy AA, Symons JM. Nephrotic syndrome in childhood. USA: Lancet. 2003;
362:629-39.
12. Sarker MN, Islam MMSU, Saad T, Shoma FN, Sharmin LS, Khan HA, dkk. Risk
factor for e in childhood nephrotic syndrome - a hospital based retrospective study.
Faridpur Med coll J. 2012;7(1):18-22.
13. Lawang SA, Rauf S, Lisal JS, Albar H, Daud D. Plasma lipids as risk factors in ing
nephrotic syndrome. Paediatr Indones. 2008;48(6):322-6.
14. Lum GM. Kidney and urinary tract. Dalam: Hay WW, Levin MJ, Sondheimer JM,
Deterding RR, penyunting. Current diagnosis and treatment pediatrics. Edisi ke-19.
USA: Lange; 2009.h.651-72.
15. Wirya IW. Sindrom nefrotik. Dalam: Alatas H, Tambunan T, Trihono PP, Pardede
SO, penyunting. Buku ajar nefrology anak. Edisi ke-12. Cetakan ke-4. Jakarta:
Badan penerbit IDAI; 2002.h.381-426.
16. Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, dkk. Evaluation and
management of proteinuria and nephrotic syndrome in children: Recomendation
from pediatric nephrology panel established at the national kidney foundation
conference on
proteinuria,
albuminuria,
risk,
assessement,
detection,
and
elimination (PARADE). American Academy of Pediatrics. 2000; 105:1242-9 Diunduh
dari www.pediatrics.appublications.org at Indonesia: AAP. Diakses pada tanggal 11
November 2014.
Universitas Sumatera Utara
17. Seigneux S, Martin PY. Management of patients with nephrotic syndrome. Swiss
Med Wkly. 2009;139(29-30):416-22.
18. Roth KS, Amaker BH, Chan JCM. Nephrotic syndrome: pathogenesis and
management.
Diunduh
dari
www.http://pedsinreview.aappublications.org
at
Indonesia: AAP. Diakses pada tanggal 10 Januari 2015.
19. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Greager MA, Olin JW,
dkk. Peripheral arterial disease detection, awareness, and treatment in primary care.
JAMA. 2001;286(11):1317-24.
20. Bendermacher BLW, Teijink JAW, Willigendael EM, Bartelink ML, Buller HR, Peters
RJG, dkk. Symptomatic peripheral arterial disease: the value of a validated
questionnaire and a clinical decision rule. Br J of Genera Pract. 2006;56:932-44.
21. Hong YM. Atherosclerosis cardiovascular disease begining in chilhood. Kcj.
2010;40(1):1-9.
22. Garcia LA. Epidemiology and pathofisiology of lower extremity peripheral arterial
disease. J Endovasc Ther. 2006;13(Suppl II):II-3-II-9.
23. Aronow WS. Peripheral arterial diseaseof the lower extremities. Arc Med Sci.
2012;8(2):375-88.
24. Khan NA, Rahim SA, Anand SS, Simel DL, Panju A. Does the clinical examination
predict lower extremity peripheral arterial disease? JAMA. 2006;295(5):536-46.
25. Criqui MH, Langer RD, Fronek A, Feigelson HR, Klauber MR, McCann TJ, dkk.
Mortality over a period of 10 years in patients with peripheral disease. N Engl J
Med.1992; 326:381-6.
Universitas Sumatera Utara
26. Hertzer NR, Beven EG, Young JR, O’hara PJ, Ruschhaupt II WF, dkk. Coronary
artery disease in peripheral vascular patients. Ann. Surg; 1984.h.223-33.
27. Ouriel K. Peripheral arterial disease. Lancet. 2001;358:1257-64.
28. Khan TH, Farooqui FA, Niazi K. Critical review of the ankle brachial index. Current
Cardiology Review. 2008;4:101-6.
29. McDermont MM, Criqui MH, Liu K, Guralnik JM, Greenland P, Martin GJ, dkk. Lower
ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior
tibial pressures, and association with leg functioning in peripheral arterial disease. J
Vasc Surg . 2000;32(6):1164-71.
30. Ostomy W, Society CN. Ankle brachial index quick reference guide for clinicians. J
Wound Ostomy continence Nurs. 2012;39(2S):S21-S9.
31. Grenon SM, Gagnon J, Hsiang Y. Ankle-brachial index for assessment of peripheral
arterial disease. N Engl J Med. 2009;361(e40):1-3.
32. Pathil AB, Kodliwadmath MV, Sonoli S. Corelation of serum cholesterol level with
urinary protein loss in nephrotic syndrome. International Journal of Medocobiological
Research. 2011;1:137-9.
33. Mark DB, Marks AD, Smith CM, editor. Biokimia kedokteran dasar Jakarta: Penerbit
buku kedokteran; 2008.
34. Gbadegesin R, Smoyer WE.Nephrotic syndrome. Dalam: Geary DF, Schaefer F.
penyunting. Comprehensive pediatric nephrology. Philadelphia; 2008.
35. National cholesterol education program (NCEP) : Higlights of the report the expert
panel on blood cholestero levels in children and adolescents. Pediatrics.1992;89:
495-501.
Universitas Sumatera Utara
36. Thabet MAEH, Salcedo JR, Chan JCM. Hyperlipidemia in childhood nephrotic
syndrome. Pediatr Nephrol. 1993;7:559-66.
37. Vinuesa SG, Ortega M, Martinez P, Goicoechea M, Campdera FG, Luno J.
Subclinical peripheral arterial disease in patients with chronic kidney disease:
Prevalence and related risk factors. Kidney Int. 2005;67(93):S44-7.
38. Fahal IH, McClelland, Hay CRM, Bell GM. Arterial thrombosis in the nephrotic
syndrome. Postgrad Med J. 1994;70:905-9.
39. Toussaint ND, Kerr PG. Vascular calcification and arterial stiffness in chronic kidney
disease: Implication and management. Nephrol. 2007;12:500-9.
40. Maxwell SRJ, Moots RJ, Kendall MJ. Corticosteroids: do they damage the
cardiovascular system? Postgrad Med J. 1994;70:863-70.
41. Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome:
Pathophysiology and clinical management. Thrombosis Research. 2006;118:397407.
42. Dahlan S, Menggunakan rumus besar sampel secara benar. Dalam: Dahlan S,
penyunting. Besar sampel dan cara pengambilan sampel dalam penelitian
kedokteran dan kesehatan. Jakarta: Sagung Seto; 2013.h.35-80.
43. Wass VJ, Chilvers C, Jarret RJ, Cameron JS. Does the nephrotic syndrome
increase the risk of cardiovaskular disease?. Lancet. 2008:664- 67.
44. Kari JA, Tashkandi M, Medhat AM, Khoja SO, Ramadan KS. Lipoprotein (a) and
other dyslipidemia in Saudi children with nephrotic syndrome (SSNS and SRNS).
Journal of Health Science. 2012;2(6):57-63.
Universitas Sumatera Utara
45. Chang J, Tsai H, Yang L, Chen T. Epidemiology and predictors of end-stage renal
disease in Taiwanese children with idiopathic nephrotic syndrome. J Epidemiol.
2012;22:517-22.
46. Vowden P, Vowden K. Doppler assessment and ABPI: Interpretation in the
management of leg ulceration. From: www.worldwidewounds.com/wowden/dopplerassessment-ABI.html. Diakses pada bulan Maret 2001.
47. Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial
disease affecting the lower extremities. Br J Surg. 1969;56:676-9.
48. Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in
the diagnosis of peripheral vascular disease. Surgery. 1982;91:686-93.
49. Zilleruelo G, Hsia SL, Freundlich M, Gorman HM, Strauss J. Persistence of serum
lipid abnormalities in children with idiopathic nephrotic syndrome. J Pediatr.
1984;104:61-4.
50. Appel GB, Blum CB, Chien S, Kunis CL, Appel AS. The hyperlipidemia of the
nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure,
and viscosity. N Engl J Med. 1985;312:1544-8.
51. Strauss J, Zilleruelo G, Freundlich M, Abitbol C. Less commonly recognized features
of childhood nephrotic syndrome. Pediatr Clin North Am. 1987;34:591-607.
Universitas Sumatera Utara
1. Park
SJ, Shin JI. Complications
of nephrotic syndrome.
Korean J Pediatr.
2011;54(8):322-8.
2. Davin JC, Rutjes NW. Nephrotic syndrome: from bench to treatment. Int J Nephrol.
2011;1-6.
3. Noer MS. Sindrom nefrotik idiopatik. Dalam: Noer MS, Soemyarso NA, Subandiyah
K, Prasetyo RV, Alatas H, dkk, penyunting. Kompendium nefrologi anak. Jakarta:
UKK nefrologi IDAI; 2011.h.72-87.
4. Pais P, Avner ED. Nephrotic syndrome. Dalam: Kliegman RM, Stanton BF, St.Geme
JW, Schor NF, Behrman RE, penyunting. Nelson texbook of pediatrics. Edisi ke-19.
USA: Elsevier saunders; 2011.h.1801-7.
5. Valentini RP, Smoyer WE. Nephrotic syndrome. Dalam: Kher KK, Schnaper HW,
Makker SP, penyunting. Clinical pediatric nephrology. Edisi ke-2. USA: Informa
healthcare; 2007.h.155-94.
6. Mohammed SM, Elmazary A, Taha HT. Ankle brachial index in children with steroidresistant nephrotic syndrome. Sultan Qaboos University Med J. 2013;13(1):88-92.
7. Willenberg T, Diehm N, Zwahlen M, Kalka D, Do DD, dkk. Impact of Long-term
corticosteroid therapy on the distribution pattern of lower limb atherosclerosis. Eur J
Vasc Endovasc Surg. 2010;39:441-6.
8. Shammas NW. Epidemiology, classification, and modifiable risk factors of peripheral
arterial disease. Vascular health and risk management. 2007;3(2):229-34.
9. Ramalhao C, Alves A, Pereira A. Arterial peripheral disease-assessment by ankle
brachial index. J Cardiol curr Res. 2014;1(4):1-6.
Universitas Sumatera Utara
10. Papa EDE, Helber I, Ehrlichmann MR, Alves CMR, Makdisse M, Matos LN, dkk.
Ankle-brachial index as a predictor of coronary disease events in elderly patients
submitted to coronary angiography. Clinics. 2013;68(12):1481-7.
11. Eddy AA, Symons JM. Nephrotic syndrome in childhood. USA: Lancet. 2003;
362:629-39.
12. Sarker MN, Islam MMSU, Saad T, Shoma FN, Sharmin LS, Khan HA, dkk. Risk
factor for e in childhood nephrotic syndrome - a hospital based retrospective study.
Faridpur Med coll J. 2012;7(1):18-22.
13. Lawang SA, Rauf S, Lisal JS, Albar H, Daud D. Plasma lipids as risk factors in ing
nephrotic syndrome. Paediatr Indones. 2008;48(6):322-6.
14. Lum GM. Kidney and urinary tract. Dalam: Hay WW, Levin MJ, Sondheimer JM,
Deterding RR, penyunting. Current diagnosis and treatment pediatrics. Edisi ke-19.
USA: Lange; 2009.h.651-72.
15. Wirya IW. Sindrom nefrotik. Dalam: Alatas H, Tambunan T, Trihono PP, Pardede
SO, penyunting. Buku ajar nefrology anak. Edisi ke-12. Cetakan ke-4. Jakarta:
Badan penerbit IDAI; 2002.h.381-426.
16. Hogg RJ, Portman RJ, Milliner D, Lemley KV, Eddy A, dkk. Evaluation and
management of proteinuria and nephrotic syndrome in children: Recomendation
from pediatric nephrology panel established at the national kidney foundation
conference on
proteinuria,
albuminuria,
risk,
assessement,
detection,
and
elimination (PARADE). American Academy of Pediatrics. 2000; 105:1242-9 Diunduh
dari www.pediatrics.appublications.org at Indonesia: AAP. Diakses pada tanggal 11
November 2014.
Universitas Sumatera Utara
17. Seigneux S, Martin PY. Management of patients with nephrotic syndrome. Swiss
Med Wkly. 2009;139(29-30):416-22.
18. Roth KS, Amaker BH, Chan JCM. Nephrotic syndrome: pathogenesis and
management.
Diunduh
dari
www.http://pedsinreview.aappublications.org
at
Indonesia: AAP. Diakses pada tanggal 10 Januari 2015.
19. Hirsch AT, Criqui MH, Treat-Jacobson D, Regensteiner JG, Greager MA, Olin JW,
dkk. Peripheral arterial disease detection, awareness, and treatment in primary care.
JAMA. 2001;286(11):1317-24.
20. Bendermacher BLW, Teijink JAW, Willigendael EM, Bartelink ML, Buller HR, Peters
RJG, dkk. Symptomatic peripheral arterial disease: the value of a validated
questionnaire and a clinical decision rule. Br J of Genera Pract. 2006;56:932-44.
21. Hong YM. Atherosclerosis cardiovascular disease begining in chilhood. Kcj.
2010;40(1):1-9.
22. Garcia LA. Epidemiology and pathofisiology of lower extremity peripheral arterial
disease. J Endovasc Ther. 2006;13(Suppl II):II-3-II-9.
23. Aronow WS. Peripheral arterial diseaseof the lower extremities. Arc Med Sci.
2012;8(2):375-88.
24. Khan NA, Rahim SA, Anand SS, Simel DL, Panju A. Does the clinical examination
predict lower extremity peripheral arterial disease? JAMA. 2006;295(5):536-46.
25. Criqui MH, Langer RD, Fronek A, Feigelson HR, Klauber MR, McCann TJ, dkk.
Mortality over a period of 10 years in patients with peripheral disease. N Engl J
Med.1992; 326:381-6.
Universitas Sumatera Utara
26. Hertzer NR, Beven EG, Young JR, O’hara PJ, Ruschhaupt II WF, dkk. Coronary
artery disease in peripheral vascular patients. Ann. Surg; 1984.h.223-33.
27. Ouriel K. Peripheral arterial disease. Lancet. 2001;358:1257-64.
28. Khan TH, Farooqui FA, Niazi K. Critical review of the ankle brachial index. Current
Cardiology Review. 2008;4:101-6.
29. McDermont MM, Criqui MH, Liu K, Guralnik JM, Greenland P, Martin GJ, dkk. Lower
ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior
tibial pressures, and association with leg functioning in peripheral arterial disease. J
Vasc Surg . 2000;32(6):1164-71.
30. Ostomy W, Society CN. Ankle brachial index quick reference guide for clinicians. J
Wound Ostomy continence Nurs. 2012;39(2S):S21-S9.
31. Grenon SM, Gagnon J, Hsiang Y. Ankle-brachial index for assessment of peripheral
arterial disease. N Engl J Med. 2009;361(e40):1-3.
32. Pathil AB, Kodliwadmath MV, Sonoli S. Corelation of serum cholesterol level with
urinary protein loss in nephrotic syndrome. International Journal of Medocobiological
Research. 2011;1:137-9.
33. Mark DB, Marks AD, Smith CM, editor. Biokimia kedokteran dasar Jakarta: Penerbit
buku kedokteran; 2008.
34. Gbadegesin R, Smoyer WE.Nephrotic syndrome. Dalam: Geary DF, Schaefer F.
penyunting. Comprehensive pediatric nephrology. Philadelphia; 2008.
35. National cholesterol education program (NCEP) : Higlights of the report the expert
panel on blood cholestero levels in children and adolescents. Pediatrics.1992;89:
495-501.
Universitas Sumatera Utara
36. Thabet MAEH, Salcedo JR, Chan JCM. Hyperlipidemia in childhood nephrotic
syndrome. Pediatr Nephrol. 1993;7:559-66.
37. Vinuesa SG, Ortega M, Martinez P, Goicoechea M, Campdera FG, Luno J.
Subclinical peripheral arterial disease in patients with chronic kidney disease:
Prevalence and related risk factors. Kidney Int. 2005;67(93):S44-7.
38. Fahal IH, McClelland, Hay CRM, Bell GM. Arterial thrombosis in the nephrotic
syndrome. Postgrad Med J. 1994;70:905-9.
39. Toussaint ND, Kerr PG. Vascular calcification and arterial stiffness in chronic kidney
disease: Implication and management. Nephrol. 2007;12:500-9.
40. Maxwell SRJ, Moots RJ, Kendall MJ. Corticosteroids: do they damage the
cardiovascular system? Postgrad Med J. 1994;70:863-70.
41. Singhal R, Brimble KS. Thromboembolic complications in the nephrotic syndrome:
Pathophysiology and clinical management. Thrombosis Research. 2006;118:397407.
42. Dahlan S, Menggunakan rumus besar sampel secara benar. Dalam: Dahlan S,
penyunting. Besar sampel dan cara pengambilan sampel dalam penelitian
kedokteran dan kesehatan. Jakarta: Sagung Seto; 2013.h.35-80.
43. Wass VJ, Chilvers C, Jarret RJ, Cameron JS. Does the nephrotic syndrome
increase the risk of cardiovaskular disease?. Lancet. 2008:664- 67.
44. Kari JA, Tashkandi M, Medhat AM, Khoja SO, Ramadan KS. Lipoprotein (a) and
other dyslipidemia in Saudi children with nephrotic syndrome (SSNS and SRNS).
Journal of Health Science. 2012;2(6):57-63.
Universitas Sumatera Utara
45. Chang J, Tsai H, Yang L, Chen T. Epidemiology and predictors of end-stage renal
disease in Taiwanese children with idiopathic nephrotic syndrome. J Epidemiol.
2012;22:517-22.
46. Vowden P, Vowden K. Doppler assessment and ABPI: Interpretation in the
management of leg ulceration. From: www.worldwidewounds.com/wowden/dopplerassessment-ABI.html. Diakses pada bulan Maret 2001.
47. Yao ST, Hobbs JT, Irvine WT. Ankle systolic pressure measurements in arterial
disease affecting the lower extremities. Br J Surg. 1969;56:676-9.
48. Ouriel K, McDonnell AE, Metz CE, Zarins CK. Critical evaluation of stress testing in
the diagnosis of peripheral vascular disease. Surgery. 1982;91:686-93.
49. Zilleruelo G, Hsia SL, Freundlich M, Gorman HM, Strauss J. Persistence of serum
lipid abnormalities in children with idiopathic nephrotic syndrome. J Pediatr.
1984;104:61-4.
50. Appel GB, Blum CB, Chien S, Kunis CL, Appel AS. The hyperlipidemia of the
nephrotic syndrome. Relation to plasma albumin concentration, oncotic pressure,
and viscosity. N Engl J Med. 1985;312:1544-8.
51. Strauss J, Zilleruelo G, Freundlich M, Abitbol C. Less commonly recognized features
of childhood nephrotic syndrome. Pediatr Clin North Am. 1987;34:591-607.
Universitas Sumatera Utara